Overall, RON activity in cancer is the result of a complex cascade of events induced by RON activation leading to direct effects on tumor progression on epithelial cancer cells and an indirect effect through the modification of immune phenotypes in the tumor microenvironment toward one that is tumor-permissive. This evidence concerns the gene MST1R and neoplasm.